Oral Oncology

Article	Citations
Staging and grading of oral squamous cell carcinoma: An update	166
Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics	123
What dentists need to know about COVID-19	123
Oral saliva and COVID-19	109
Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks	94
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws	79
Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base	75
Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review	71
Linking chronic periodontitis and oral cancer: A review	67
Social media and telemedicine for oral diagnosis and counselling in the COVID-19 era	67
Systematic review of international guidelines for tracheostomy in COVID-19 patients	65
CORONA-steps for tracheotomy in COVID-19 patients: A staff-safe method for airway management	62
The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study	62
Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions	60
Hybrid oral potentially malignant disorder: A neglected fact in oral submucous fibrosis	49
Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies	49
Transoral thyroidectomy (TOETVA): Complications, surgical time and learning curve	48
Development of a self-constrained 3D DenseNet model in automatic detection and segmentation of nasopharyngeal carcinoma using magnetic resonance images	48
Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection	47
Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis	47
Screening for oral cancer: Future prospects, research and policy development for Asia	45
The contribution of artificial intelligence to reducing the diagnostic delay in oral cancer	43
The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis	43
Dosiomics improves prediction of locoregional recurrence for intensity modulated radiotherapy treated head and neck cancer cases	41
Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma	41

Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic	40
Targeting tumor-associated macrophages in head and neck squamous cell carcinoma	40
Assessment of tumour depth in early tongue cancer: Accuracy of MRI and intraoral ultrasound	38
Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI	38
Trans-oral robotic surgery in the management of parapharyngeal space tumors: A systematic review	37
Composition and function of oral microbiota between gingival squamous cell carcinoma and periodontitis	36
De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials	35
Gender and race interact to influence survival disparities in head and neck cancer	35
Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer	34
Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study	33
Elective neck dissection versus observation for early-stage oral squamous cell carcinoma: Systematic review and meta-analysis	33
Enhanced recovery after surgery for head and neck free flap reconstruction: A systematic review and meta-analysis	33
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma	32
Clinicopathological and prognostic characteristics of oral squamous cell carcinomas arising in patients with oral lichen planus: A systematic review and a comprehensive meta-analysis	32
A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma	31
MicroRNAs in oral cancer: Biomarkers with clinical potential	31
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311	31
The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages	30
TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells	30
Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration	29
Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis	28
microRNAs in oral cancer: Moving from bench to bed as next generation medicine	28
Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancer	27
Do predetermined surgical margins compromise oncological safety in computer-assisted head and neck reconstruction?	27
De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?	27
Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis	27
Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients	27
Clinical label-free biochemical and metabolic fluorescence lifetime endoscopic imaging of precancerous and cancerous oral lesions	27
Imaging in oral cancers: A comprehensive review	27
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck	26
Current opinions on diagnosis and treatment of adenoid cystic carcinoma	26
Head and neck cancer care in the COVID-19 pandemic: A brief update	26
Impact of COVID-19 on the early detection of oral cancer: A special emphasis on high risk populations	25
Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study	25
The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma	25
Single-cell profiling of tumor-infiltrating TCF1/TCF7+ T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer	25
Surgical, clinical and functional outcomes of transoral robotic surgery for supraglottic laryngeal cancers: A systematic review	24
Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A do	24
Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control – Comparison with conventional treatment	24
The interplay of the oral microbiome and alcohol consumption in oral squamous cell carcinomas	24
The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis	24
Oral cancer incidence rates from 1997 to 2016 among men in Taiwan: Association between birth cohort trends and betel nut consumption	24
Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis	23
Lymph node yield and lymph node ratio in oral cavity and oropharyngeal carcinoma: Preliminary results from a prospective, multicenter, international cohort	23
Cosmetic outcomes after transoral robotic thyroidectomy: Comparison with transaxillary, postauricular, and conventional approaches	22
Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients	22
Association of significant financial burden with survival for head and neck cancer patients treated with radiation therapy	22
Past, present and future of proton therapy for head and neck cancer	22
Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery	22
CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells	22

Provision of continuous dental care for oral oncology patients during & after COVID-19 pandemic	22
The role of computer aided design/computer assisted manufacturing (CAD/CAM) and 3- dimensional printing in head and neck oncologic surgery: A review and future directions	22
The relevance of surgical margins in clinically early oral squamous cell carcinoma	22
Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma	22
Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activi	21
Obesity and the prevention of thyroid cancer: Impact of body mass index and weight change on developing thyroid cancer – Pooled results of 24 million cohorts	21
Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis	21
HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis	21
PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data	21
Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma	21
P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines	21
Sex disparities in head & neck cancer driver genes: An analysis of the TCGA dataset	21
Periodontitis and oral Cancer-A striking link	20
Direct costs associated with the management of mucositis: A systematic review	20
Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma	20
State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients	20
Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma	20
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing	20
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma	20
An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features	20
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge	20
The utility of intra-oral ultrasound in improving deep margin clearance of oral tongue cancer resections	19
Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment	19
Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: A prospective study	19
Sinonasal cancer encroaching the orbit: Ablation or preservation?	19
Feasibility and efficacy of intraoperative neural monitoring in remote access robotic and endoscopic thyroidectomy	19
Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study	19
Cutaneous squamous cell carcinoma in the organ transplant recipient	19
Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer	19
The impact of nodal status in major salivary gland carcinoma: A multicenter experience and proposal of a novel N-classification	19
Individualized cumulative cisplatin dose for locoregionally-advanced nasopharyngeal carcinoma patients receiving induction chemotherapy and concurrent chemoradiotherapy	19
An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging	18
Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders	18
cfDNA detection for HPV+ squamous cell carcinomas	18
Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review	18
Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma	18
Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer	18
Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer	18
Reprint of “Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up”	18
Voice outcomes of transoral robotic thyroidectomy: Comparison with conventional trans-cervical thyroidectomy	18
Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck	18
Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells	17
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients	17
Trans oral robotic surgery versus definitive chemoradiotherapy for oropharyngeal cancer: 10-year institutional experience	17
Effectiveness of a guided self-help exercise program tailored to patients treated with total laryngectomy: Results of a multi-center randomized controlled trial	17
Recurrent laryngeal nerve management in transoral endoscopic thyroidectomy	17
External validation of nodal failure prediction models including radiomics in head and neck cancer	17
Successful treatment of advanced pulmonary sarcomatoid carcinoma with the PD-1 inhibitor toripalimab: A case report	17
Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity	17
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis	17
Predictors of surgical readmission, unplanned hospitalization and emergency department use in head and neck oncology: A systematic review	17
Treatment implications of postoperative chemoradiotherapy for squamous cell carcinoma of the oral cavity with minor and major extranodal extension	17
Impact of 3 mm margin on risk of recurrence and survival in oral cancer	17
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048	17
European Head and Neck Society recommendations for head and neck cancer survivorship care	17
Selection of the surgical approach for lesions with parapharyngeal space involvement: A single-center experience on 153 cases	16
Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal c	16
Surgical tracheostomies in COVID-19 patients: A multidisciplinary approach and lessons learned	16
A multicenter validation of the revised version of the Milan system for reporting salivary gland cytology (MSRSGC)	16
Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis	16
A review of breath analysis techniques in head and neck cancer	16
Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck	16
Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance	16
Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database	16
Trends in the global burden of oral cancer joint with attributable risk factors: Results from the global burden of disease study 2019	15
Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation	15
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers	15
Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study	15
Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?	15
Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma	15
Application and accuracy of ultrasound-guided resections of tongue cancer	15
Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review	15
Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG	15
Oral cancer in India, a growing problem: Is limiting the exposure to avoidable risk factors the only way to reduce the disease burden?	15
Preoperative evaluation of depth of invasion in oral tongue squamous cell carcinoma: A systematic review and meta-analysis	15
Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity	15
Diagnostic accuracy of imaging modalities in detection of histopathological extranodal extension: A systematic review and meta-analysis	15
COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings	14
Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer	14
Lichenoid dysplasia is not a distinct pathological entity	14

Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy- results of a longitudinal study	14
The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis	14
A critical evaluation of computed tomography-derived depth of invasion in the preoperative assessment of oral cancer staging	14
The impact of early oral feeding following head and neck free flap reconstruction on complications and length of stay	14
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis	14
Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional study	14
The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma	14
RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers	14
Duration of radiation therapy is associated with worse survival in head and neck cancer	14
Optimum surgical margins in squamous cell carcinoma of the oral tongue: Is the current definition adequate?	14
Overestimated risk of transformation in oral lichen planus	14
Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis	14
Dysbiotic tumor microbiota associates with head and neck squamous cell carcinoma outcomes	14
Public health measures to reduce areca nut and betel quid use for control of oral cancer in Taiwan	14
Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial	14
Case series of docetaxel, trastuzumab, and pertuzumab (DTP) as first line anti-HER2 therapy and ado-trastuzumab emtansine (T-DM1) as second line for recurrent or metastatic HER2-positive salivary duct	14
Mathematical oncology and it’s application in non melanoma skin cancer – A primer for radiation oncology professionals	14
All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles	13
Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience	13
Continuing education in oral cancer during coronavirus disease 2019 (covid-19) outbreak	13
Confocal laser endomicroscopy and confocal microscopy for head and neck cancer imaging: Recent updates and future perspectives	13
Health-related quality of life in maxillectomy patients undergoing dentoalveolar rehabilitation	13
Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy	13
Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma	13
Multifaceted multinucleated giant cells in oral squamous cell carcinoma	13
Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment	13
The impact of positive margin on survival in oral cavity squamous cell carcinoma	13
Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial	12
Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival	12
Countermeasure and opportunistic screening systems for oral cancer	12
A probable surge in oral lichen planus cases under the aura of coronavirus in females in India	12
Postoperative oral dysfunction following oral cancer resection and reconstruction: A preliminary cross-sectional study	12
HCV infection and the risk of head and neck cancer: A meta-analysis	12
Circumferential pharyngeal reconstruction after total laryngopharyngectomy: A systematic review and network meta-analysis	12
Impact of HPV status on immune responses in head and neck squamous cell carcinoma	12
Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review	12
Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation	12
Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation	12
Outcomes in patients diagnosed with tongue cancer before and after the age of 45 years	12
Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence	12
Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial	12
Positive margins matter regardless of subsequent resection findings	12
Tumor histologic grade as a risk factor for neck recurrence in patients with T1-2N0 early tongue cancer	12
Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma	12
Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study	12
Effectiveness of physical activity interventions in improving objective and patient-reported outcomes in head and neck cancer survivors: A systematic review	12
Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma	12
The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study	12
Molecular margins in head and neck cancer: Current techniques and future directions	12
Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation	12
Comparing outcomes of radial forearm free flaps and anterolateral thigh free flaps in oral cavity reconstruction: A systematic review and meta-analysis	12
Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial	12
Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database	12
Concordance of tumor infiltrating lymphocytes, PD-L1 and p16 expression in small biopsies, resection and lymph node metastases of oropharyngeal squamous cell carcinoma	12
Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC)	11
Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma	11
Prognostic impact of regulatory T cell in head and neck squamous cell carcinoma: A systematic review and meta-analysis	11
Radiation-induced second primary squamous cell carcinoma of the oral cavity after radiotherapy for nasopharyngeal carcinoma	11
Impact of histological Oral Tongue Cancer margins on locoregional recurrence: A multi-centre retrospective analysis	11
The impact of an educational video about radiotherapy and its toxicities in head and neck cancer patients. Evaluation of patients’ understanding, anxiety, depression, and quality of life	11
Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience	11
Cost-effectiveness analysis of gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil for induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma	11
Reducing the unknowns: A systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary	11
The head and neck cancer genome in the era of immunotherapy	11
Nivolumab-related lichen planus of the lip in a patient with head and neck cancer	11
Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma	11
Combinatorial approaches targeting the EGFR family and c-Met in SCCHN	11
Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation	11
Reconstruction of the oral cavity; past, present and future	11
Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: Importance of nodal count in survival	11
CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients	11
New AJCC: How does it impact oral cancers?	11
Head and neck cancer cannot wait for this pandemic to end: Risks, challenges and perspectives of oral-maxillofacial surgeon during COVID-19	11
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes	11
Prediction of treatment outcome using MRI radiomics and machine learning in oropharyngeal cancer patients after surgical treatment	11
Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning	11
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma	11
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis	11
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience	11
Management of early oral cavity squamous cancers	11
Safe management of laryngectomized patients during the COVID-19 pandemic	11
Relationship of depth of invasion to survival outcomes and patterns of recurrence for T3 oral tongue squamous cell carcinoma	11
Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma	11
Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer	11
Management of locally advanced oral cancers	11
Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma	11
A prospective randomized controlled trial on the value of prophylactic oral nutritional supplementation in locally advanced nasopharyngeal carcinoma patients receiving chemo-radiotherapy	11
Discarded Covid 19 gear: A looming threat	11
A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101	11
Survivin expression and impact on head and neck cancer outcomes	11
The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis	10
SARS-CoV-2 in upper and lower airway samples of a laryngectomized patient: New insights and many lessons	10
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab	10
Management of tracheostomy during COVID-19 outbreak: Heat and moisture exchanger filter and closed suctioning system	10
Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma	10